There is an urgent need for new vaccines, diagnostics, and treatments to address high mortality and morbidity associated with infectious disease. The current system of motivating research and development favours the needs of people in developed countries, while neglecting many diseases that primarily affect people in developing countries. This is according to a message from Medicines Sans Frontiers about access to medicines, made to the 56th World Health Assembly (WHA), held between May 19-28.